Anti-viral compounds

US12252481B2 · kind B2 · utility

Assignees

• Aligos Therapeutics, Inc. · US
• Katholieke Universiteit Leuven · BE

Inventors

• Koen Vandyck · Beringen, BE
• Dorothée Alice Marie-Eve Bardiot · Leuven, BE
• Pierre Jean-Marie Bernard Raboisson · Sligo, IE
• Leonid Beigelman · San Mateo, US
• Antitsa Dimitrova Stoycheva · Rue de l'Église, US
• Sandro Boland · Diepenbeek, BE
• Arnaud Marchand · Leuven, BE

Key dates

• Filing date: Oct 13, 2023
• Grant date: Mar 18, 2025
• Expiry date: Oct 13, 2043

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are compounds of Formula (I), or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include a compound described herein (including pharmaceutically acceptable salts of a compound described herein) and methods of synthesizing the same. Also provided herein are methods of treating diseases and/or conditions with a compound of Formula (I), or a pharmaceutically acceptable salt thereof.